Skip to main content

Table 1 Patient characteristics at baseline

From: Omalizumab for chronic urticaria in Latin America

Characteristic

Mean age, years (range)

47.8 (18–81)

Sex: female, n (%)

15 (57.7)

Mean duration of CU, months (range)

23.3 (2–180)

Mean IgE, kU/L (range)

570.6 (55–2500)

Differential diagnosis of thyroid disease, n (%)

10 (38.5)

Comorbidities, n (%)

6 (23.1)

Previous medication, n (%)

26 (100)

-First-generation antihistamines alone

5 (19.2)

-Second-generation antihistamines alone

6 (23.1)

-First-generation antihistamines plus corticosteroids

3 (11.5)

-Second-generation antihistamines plus corticosteroids

11 (42.3)

-First- and second-generation antihistamines

1 (3.8)

  1. CU chronic urticaria, IgE immunoglobulin E